| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $203.4M | -21.5% |
| Cost of Revenue | $94.1M | -22.8% |
| Gross Profit | $109.3M | -20.4% |
| R&D Expense | $18.5M | +12.5% |
| SG&A Expense | $103.2M | -23.5% |
| Operating Income | -$22.5M | +36.1% |
| Pre-tax Income | -$27.4M | +36.6% |
| Income Tax | $40K | +5.3% |
| Net Income | -$27.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.6M | -77.3% |
| Inventory | $19.4M | -32.8% |
| Current Assets | $44.9M | -63.8% |
| Total Assets | $65.0M | -56.9% |
| Current Liabilities | $27.1M | -22.8% |
| Long-term Debt | $7.5M | -89.5% |
| Total Liabilities | $48.8M | -63.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.7M | -22.0% |
| Capital Expenditures | $1.8M | -41.1% |
| Investing Cash Flow | -$1.6M | +45.7% |
| Financing Cash Flow | -$59.2M | -700.5% |
| Free Cash Flow | -$11.5M | -4.8% |
| +36.6% |
| EPS (Basic) | -$0.76 | +40.6% |
| EPS (Diluted) | -$0.76 | +40.6% |
| Stockholders' Equity |
| -$8.5M |
| -205.3% |